Differences in Lung Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Semi-Structured Qualitative Study in China

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• World Health Organization. International agency for research on cancer. China fact sheets; 2018. Available from: https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf. Accessed March 26, 2021.
   Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang Z, Wang Q. Emerging therapies for small cell lung cancer. J Hematol Oncol. 2019;12(1):47. doi:10.1186/s13045-019-0736-3
   PubMed Web of Science ®Google Scholar
• Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin proc. 2019;94(8):1623–1640. doi:10.1016/j.mayocp.2019.01.013
   PubMed Web of Science ®Google Scholar
• Steven A, Fisher SA, Robinson BW. Immunotherapy for lung cancer. Respirology. 2016;21(5):821–833. doi:10.1111/resp.12789
   PubMed Web of Science ®Google Scholar
• Ricciardi S, Tomao S, de Marinis F. Toxicity of targeted therapy in non-small-cell lung cancer management. Clin Lung Cancer. 2009;10(1):28–35. doi:10.3816/CLC.2009.n.004
   PubMed Web of Science ®Google Scholar
• Barry MJ, Edgman-Levitan S. Shared decision making–pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780–781. doi:10.1056/NEJMp1109283
   PubMed Web of Science ®Google Scholar
• Frosch DL, Kaplan RM. Shared decision making in clinical medicine: past research and future directions. Am J Prev Med. 1999;17(4):285–294. doi:10.1016/S0749-3797(99)00097-5
   PubMed Web of Science ®Google Scholar
• Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA. 1992;267(16):2221–2226. doi:10.1001/jama.1992.03480160079038
   PubMed Web of Science ®Google Scholar
• Ting X, Yong B, Yin L, Mi T. Patient perception and the barriers to practicing patient-centered communication: a survey and in-depth interview of Chinese patients and physicians. Patient Educ Couns. 2016;99(3):364–369. doi:10.1016/j.pec.2015.07.019
   PubMed Web of Science ®Google Scholar
• Rui D. A family-oriented decision-making model for human research in Mainland China. J Med Philos. 2015;40(4):400–417. doi:10.1093/jmp/jhv013
   Web of Science ®Google Scholar
• Lin ML, Huang CT, Chen CH. Reasons for family involvement in elective surgical decision-making in Taiwan: a qualitative study. J Clin Nurs. 2017;26(13–14):1969–1977. doi:10.1111/jocn.13600
   Web of Science ®Google Scholar
• Hobbs GS, Landrum MB, Arora NK, et al. The role of families in decisions regarding cancer treatments. Cancer. 2015;121(7):1079–1087. doi:10.1002/cncr.29064
   PubMed Web of Science ®Google Scholar
• Hahne J, Liang T, Khoshnood K, Wang X, Li X. Breaking bad news about cancer in China: concerns and conflicts faced by doctors deciding whether to inform patients. Patient Educ Couns. 2020;103(2):286–291. doi:10.1016/j.pec.2019.08.022
   Web of Science ®Google Scholar
• Pacchiana MV, Capelletto E, Carnio S, et al. Patients’ attitudes and physicians’ perceptions toward maintenance therapy for advanced non-small-cell lung cancer: a multicenter Italian survey. Clin Lung Cancer. 2017;18(4):381–387. doi:10.1016/j.cllc.2016.10.002
   PubMed Web of Science ®Google Scholar
• Blinman P, Hughes B, Crombie C, et al. Patients’ and doctors’ preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: what makes it worthwhile? Eur j Cancer. 2015;51(12):1529–1537. doi:10.1016/j.ejca.2015.05.022
   PubMed Web of Science ®Google Scholar
• McMullen S, Hess LM, Kim ES, et al. Treatment decisions for advanced non-squamous non-small cell lung cancer: patient and physician perspectives on maintenance therapy. patient. 2019;12(2):223–233. doi:10.1007/s40271-018-0327-3
   PubMedGoogle Scholar
• Teddlie C, Yu F. Mixed methods sampling. J Mix Methods Res. 2016;1:77–100. doi:10.1177/1558689806292430
   Google Scholar
• Sun Y, Gregersen H, Yuan W. Chinese health care system and clinical epidemiology. Clin Epidemiol. 2017;9:167–178. doi:10.2147/CLEP.S106258
   Web of Science ®Google Scholar
• Sun H, Wang H, Shi L, et al. Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments. BMJ Open. 2020;10(2):e032336. doi:10.1136/bmjopen-2019-032336
   PubMed Web of Science ®Google Scholar
• Gonzalez JM, Doan J, Gebben DJ, Boeri M, Fishman M. Comparing the relative importance of attributes of metastatic renal cell carcinoma treatments to patients and physicians in the united states: a discrete-choice experiment. PharmacoEconomics. 2018;36(8):973–986. doi:10.1007/s40273-018-0640-7
   Web of Science ®Google Scholar
• Bolt T, Mahlich J, Nakamura Y, Nakayama M. Hematologists’ preferences for first-line therapy characteristics for multiple myeloma in Japan: attribute rating and discrete choice experiment. Clin Ther. 2018;40(2):296–308.e292. doi:10.1016/j.clinthera.2017.12.012
   PubMed Web of Science ®Google Scholar
• Wieland J, Hoppe BS, Rausch-Osian SM, et al. Survivor and caregiver expectations and preferences regarding lung cancer treatment. Int j Part Ther. 2019;6(2):42–49. doi:10.14338/IJPT-19-00072.1
   Google Scholar
• Jen W-Y, Yoong J, Liu X, Tan MSY, Chng WJ, Chee Y-L. Qualitative study of factors affecting patient, caregiver and physician preferences for treatment of myeloma and indolent lymphoma. Patient Prefer Adherence. 2020;14:301–308. doi:10.2147/PPA.S241340
   Web of Science ®Google Scholar
• Leng J, Lui F, Chen A, Huang X, Gany F. Adapting meaning-centered psychotherapy in advanced cancer for the Chinese immigrant population. J Immigrant Minority Health. 2017;20(11 Suppl):1–7.
   Google Scholar
• Somers C, Chimonas S, McIntosh E, Kaltenboeck A, Briggs A, Bach P. Using nominal group technique to identify key attributes of oncology treatments for a discrete choice experiment. MDM Policy Pract. 2019;4(1):2381468319837925. doi:10.1177/2381468319837925
   Google Scholar
• Lee JY, Kim K, Lee YS, et al. Treatment preferences of advanced ovarian cancer patients for adding bevacizumab to first-line therapy. Gynecol Oncol. 2016;143(3):622–627. doi:10.1016/j.ygyno.2016.10.021
   PubMed Web of Science ®Google Scholar
• Smith SK, Nicolla J, Zafar SY. Bridging the gap between financial distress and available resources for patients with cancer: a qualitative study. J Oncol Pract. 2014;10(5):e368–e372. doi:10.1200/JOP.2013.001342
   PubMedGoogle Scholar
• Lang HC. Willingness to pay for lung cancer treatment. Value Health. 2010;13(6):743–749. doi:10.1111/j.1524-4733.2010.00743.x
   PubMed Web of Science ®Google Scholar
• Schmidt K, Damm K, Vogel A, et al. Therapy preferences of patients with lung and colon cancer: a discrete choice experiment. Patient Prefer Adherence. 2017;11:1647–1656. doi:10.2147/PPA.S138863
   Web of Science ®Google Scholar
• Muhlbacher AC, Bethge S. Patients’ preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer. Eur J Health Econ. 2015;16(6):657–670. doi:10.1007/s10198-014-0622-4
   PubMed Web of Science ®Google Scholar
• Bridges J, Cruz M, Pavilack M. et al. Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancer. Future Oncol;2019. 15. doi: 10.2217/fon-2019-0396
   Web of Science ®Google Scholar
• Tong BC, Wallace S, Hartwig MG, D’Amico TA, Huber JC. Patient preferences in treatment choices for early-stage lung cancer. Ann Thorac Surg. 2016;102(6):1837–1844. doi:10.1016/j.athoracsur.2016.06.031
   Web of Science ®Google Scholar
• Gerber DE, Hamann HA, Rasco DW, Woodruff S, Lee SJ. Patient comprehension and attitudes toward maintenance chemotherapy for lung cancer. Patient Educ Couns. 2012;89(1):102–108. doi:10.1016/j.pec.2012.04.013
   Web of Science ®Google Scholar
• Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. Onco Targets Ther. 2016;9:1023–1028. doi:10.2147/OTT.S100685
   PubMed Web of Science ®Google Scholar
• Gralla RJ, Griesinger F. Interpreting clinical trials in lung cancer: impact of methodology and endpoints. J Thorac Oncol. 2007;2(Suppl 2):S51–S58. doi:10.1097/01.JTO.0000269734.27047.3e
   Web of Science ®Google Scholar
• Camps C, Del Pozo N, Blasco A, Blasco P, Sirera R. Importance of quality of life in patients with non-small-cell lung cancer. Clin Lung Cancer. 2009;10(2):83–90. doi:10.3816/CLC.2009.n.010
   Web of Science ®Google Scholar
• Longtin Y, Sax H, Leape LL, Sheridan SE, Donaldson L, Pittet D. Patient participation: current knowledge and applicability to patient safety. Mayo Clin proc. 2010;85(1):53–62. doi:10.4065/mcp.2009.0248
   PubMed Web of Science ®Google Scholar
• Ho A. Relational autonomy or undue pressure? Family’s role in medical decision-making. Scand J Caring Sci. 2008;22(1):128–135. doi:10.1111/j.1471-6712.2007.00561.x
   PubMed Web of Science ®Google Scholar